Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2025-12-26 @ 1:59 AM
NCT ID: NCT02176005
Description: None
Frequency Threshold: 0
Time Frame: Treatment period: - 5 days for Moxifloxacin group; - 7 days for the 3 other groups (DAV132 + Moxifloxacin, DAV132 and Negative Control groups)
Study: NCT02176005
Study Brief: Safety and Efficacy Study of DAV132 in Healthy Volunteers
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Moxifloxacin Moxifloxacin (400mg x1/day taken orally for 5 days) used alone 0 None 0 14 6 14 View
Moxifloxacin + DAV132 DAV132 (7.5g x3/day taken orally for 7 days) associated to Moxifloxacin (400mg x1/day taken orally for 5 days) 0 None 0 14 10 14 View
DAV132 DAV132 (7.5g x3/day taken orally for 7 days) used alone 0 None 0 8 2 8 View
Negative Control Negative control: microcrystalline cellulose (7.5g x3/day taken orally for 7 days) 0 None 0 8 1 8 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.0) View
Flatulence SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.0) View
Ligament sprain SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.0) View
Intestinal transit time abnormal SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.0) View
Formication SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.0) View
Syncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.0) View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.0) View
Dysmenorrhoea SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (17.0) View
Vulvovaginal mycotic infection SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (17.0) View
Oropharyngeal pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.0) View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.0) View
Asthenia SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.0) View
Pollakiuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (17.0) View